Extensive epidemiologic and genetic evidence demonstrates that Lp(a) is an independent risk factor for atherosclerotic cardiovascular disease but questions remain over its impact in patients with well controlled LDL-C levels and other risk factors. Professor Sam Tsimikas, University of California San Diego, USA, puts the evidence under the spotlight.
Please login or create a FREE account to view this content
Educational Partners of the 2nd Closed Scientific Expert Meeting of the Editorial Board
Principal partners:
Guest partners:
